2018
DOI: 10.4103/2221-6189.228874
|View full text |Cite
|
Sign up to set email alerts
|

Neuroprotective effects of progesterone in acute brain trauma and its physiological mechanism

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2021
2021
2022
2022

Publication Types

Select...
1
1

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 4 publications
0
2
0
Order By: Relevance
“…We contemplated various aspects of NOS like the ability to cross BBB; antagonism of bradykinin receptors; effect of bradykinin antagonism, ultimately reduced in ammation, on ischemia; high safety pro le; its cytoprotective activity; ease of administration and inexpensive use for the treatment of other pathological conditions (Souza et al 2003;Landen et al 2004). Moreover, PG and NOS have been reported for their bene cial effect on the ischemic injury but both agents exhibited different mechanisms to reduce brain damage (Mahmoudian et al 2003;Mahmoudian et al 2015;Moscote -Salazar et al 2018;Guennoun 2019).…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…We contemplated various aspects of NOS like the ability to cross BBB; antagonism of bradykinin receptors; effect of bradykinin antagonism, ultimately reduced in ammation, on ischemia; high safety pro le; its cytoprotective activity; ease of administration and inexpensive use for the treatment of other pathological conditions (Souza et al 2003;Landen et al 2004). Moreover, PG and NOS have been reported for their bene cial effect on the ischemic injury but both agents exhibited different mechanisms to reduce brain damage (Mahmoudian et al 2003;Mahmoudian et al 2015;Moscote -Salazar et al 2018;Guennoun 2019).…”
Section: Introductionmentioning
confidence: 99%
“…We also determined vital pharmacokinetic parameters in the brain and plasma to substantiate the pharmacological actions of the co-administration of both agents. Progesterone (PG), a neurosteroid, exhibits neuroprotection effects by modulating the transcription of target genes by interacting with intracellular progesterone receptors (PR) and neural PR (Gruenbaum et al 2016; Gaignard et al 2017;Zhu et al 2017;Moscote-Salazar et al 2018;Guennoun et al 2019). PG promotes regeneration of central myelin and regulates in ammation by microglia stabilization (Ghoumari et al 2005;El-Etr et al 2015).…”
Section: Introductionmentioning
confidence: 99%